Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR1432) | ||||||
---|---|---|---|---|---|---|
Drug Name |
CS-011
|
|||||
Synonyms |
R 106056; R-106056; Rivoglitazone; Rivoglitazone (USAN/INN); Rivoglitazone [USAN:INN]; SCHEMBL143498; XMSXOLDPMGMWTH-UHFFFAOYSA-N; (5s)-5-({4-[(6-Methoxy-1-Methyl-1h-Benzimidazol-2-Yl)methoxy]phenyl}methyl)-1,3-Thiazolidine-2,4-Dione; 185428-18-6; 5-[4-(6-Methoxy-1-Methylbenzimidazol-2-Ylmethoxy)-Benzyl]Thiazolidine-2,4-Dione; 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione; AC1MHOZ3; ACM185428186; AN-17038; BCP06166; CHEMBL2104753; CS-011; D05739; DB09200; DE-101
|
|||||
Indication | Diabetes mellitus [ICD11: 5A10] | Phase 3 | [1] | |||
Structure | ||||||
3D MOL | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 397.4 | Topological Polar Surface Area | 108 | ||
Heavy Atom Count | 28 | Rotatable Bond Count | 6 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 6 | |||
Cross-matching ID |
|
|||||
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.